ASLAN Pharmaceuticals Limited American Depositary Shares
ASLN
ASLN was delisted on the 18th of July, 2024.
9 hedge funds and large institutions have $6.97M invested in ASLAN Pharmaceuticals Limited American Depositary Shares in 2020 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 3 closing their positions.
103% more capital invested
Capital invested by funds: $3.43M → $6.97M (+$3.54M)
0% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 2
18% less funds holding
Funds holding: 11 → 9 (-2)
67% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Sio Capital Management
New York
|
+$139K |
| 2 |
Renaissance Technologies
New York
|
+$89.8K |
| 3 |
Millennium Management
New York
|
+$32.4K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$23K |
| 2 |
Morgan Stanley
New York
|
-$5.91K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$4.28K |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$1K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
1
Temasek Holdings
Singapore
| $2.85M | – | – | – |
|
|
SCM
2
Sio Capital Management
New York
| $2.75M | +$139K | +2,051 | +6% |
|
|
PIM
3
Platinum Investment Management
Sydney Australia 2000,
Australia
| $831K | – | – | – |
|
|
4
Renaissance Technologies
New York
| $256K | +$89.8K | +1,322 | +70% |
|
|
DCM
5
DAFNA Capital Management
Los Angeles,
California
| $172K | – | – | – |
|
6
Bank of Montreal
Toronto,
Ontario, Canada
| $58K | – | – | – |
|
|
7
Millennium Management
New York
| $37K | +$32.4K | +477 | New |
|
|
8
Morgan Stanley
New York
| $18K | -$5.91K | -87 | -27% |
|
|
9
UBS Group
Zurich,
Switzerland
| $3K | -$4.28K | -63 | -63% |
|
|
10
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$23K | -569 | Closed |
|
|
11
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| – | -$1K | -30 | Closed |
|
ASLN Hedge Fund Activity: Q2 2020 in Review
9 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in ASLAN Pharmaceuticals Limited American Depositary Shares (ASLN) for Q2 2020, worth a combined $6.97M — up 103% from $3.43M a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of ASLN and 1 opened new positions — a net loss of 2 holders — while 2 trimmed existing stakes and 2 added.
The largest buyer was Sio Capital Management, adding an estimated $139K. The largest seller was Susquehanna International Group, exiting entirely with an estimated $23K sold.
- 9 institutional investors held ASLAN Pharmaceuticals Limited American Depositary Shares (ASLN) as of Q2 2020, down from 11 in Q1 2020.
- Funds reported $6.97M of ASLAN Pharmaceuticals Limited American Depositary Shares stock for Q2 2020, up 103% quarter-over-quarter.
- 1 fund opened new ASLAN Pharmaceuticals Limited American Depositary Shares positions in Q2 2020 and 3 closed out, a net change of -2 holders.
- The largest ASLAN Pharmaceuticals Limited American Depositary Shares buyer in Q2 2020 was Sio Capital Management, an estimated $139K added.
- The largest ASLAN Pharmaceuticals Limited American Depositary Shares seller in Q2 2020 was Susquehanna International Group, an estimated $23K sold.
Based on aggregated 13F filings for Q2 2020.